| NASDAQ (usa) |
|
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
| DAX (german) |
|
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Suzhou Zelgen Biopharmaceuticals Co. Ltd (SHG: 688266)
688266 Technical Analysis
4
| As on 29th Oct 2025 688266 STOCK Price closed @ 87.00 and we RECOMMEND Buy for LONG-TERM with Stoploss of 64.36 & Strong Buy for SHORT-TERM with Stoploss of 54.84 we also expect STOCK to react on Following IMPORTANT LEVELS. |
688266STOCK Price
| Open | 102.56 | Change | Price | % |
| High | 102.56 | 1 Day | -12.97 | -12.97 |
| Low | 84.91 | 1 Week | -15.95 | -15.49 |
| Close | 87.00 | 1 Month | -29.35 | -25.23 |
| Volume | 10793551 | 1 Year | 35.84 | 70.05 |
| 52 Week High 133.48 | 52 Week Low 49.89 | ||||
SHG China Most Active Stocks
| 600221 | 1.75 | 3.55% |
| 600705 | 3.47 | 0.29% |
| 600811 | 0.36 | -2.70% |
| 600010 | 2.62 | 1.16% |
| 600157 | 1.65 | 1.23% |
| 600219 | 4.57 | 10.12% |
| 601989 | 5.10 | 1.80% |
| 600016 | 3.97 | -1.49% |
| 601600 | 9.91 | 7.02% |
| 600601 | 13.52 | 2.50% |
SHG China Top Gainers Stocks
SHG China Top Losers Stocks
| 688266 Daily Charts |
688266 Intraday Charts |
Whats New @ Bazaartrend |
688266 Free Analysis |
|
|
688266 Important Levels Intraday
| RESISTANCE | 121.01 |
| RESISTANCE | 110.10 |
| RESISTANCE | 103.36 |
| RESISTANCE | 96.62 |
| SUPPORT | 77.38 |
| SUPPORT | 70.64 |
| SUPPORT | 63.90 |
| SUPPORT | 52.99 |
688266 Forecast October 2025
| 4th UP Forecast | 102.38 |
| 3rd UP Forecast | 97.45 |
| 2nd UP Forecast | 94.4 |
| 1st UP Forecast | 91.35 |
| 1st DOWN Forecast | 82.65 |
| 2nd DOWN Forecast | 79.6 |
| 3rd DOWN Forecast | 76.55 |
| 4th DOWN Forecast | 71.62 |
688266 Weekly Forecast
| 4th UP Forecast | 93.71 |
| 3rd UP Forecast | 91.56 |
| 2nd UP Forecast | 90.23 |
| 1st UP Forecast | 88.90 |
| 1st DOWN Forecast | 85.10 |
| 2nd DOWN Forecast | 83.77 |
| 3rd DOWN Forecast | 82.44 |
| 4th DOWN Forecast | 80.29 |
688266 Forecast2025
| 4th UP Forecast | 251.12 |
| 3rd UP Forecast | 198.49 |
| 2nd UP Forecast | 165.95 |
| 1st UP Forecast | 133.42 |
| 1st DOWN Forecast | 40.58 |
| 2nd DOWN Forecast | 8.05 |
| 3rd DOWN Forecast | -24.49 |
| 4th DOWN Forecast | -77.12 |
Suzhou Zelgen Biopharmaceuticals Co. Ltd ( SHG China Symbol : 688266 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
688266 Other Details
| Segment | EQ | |
| Market Capital | 14817600512.00 | |
| Sector | Healthcare | |
| Industry | Biotechnology | |
| Offical website | > echo $website ; ?> | |
688266 Address
![]() |
||
688266 Latest News
688266 Business Profile
Suzhou Zelgen Biopharmaceuticals Co., Ltd. researches and develops, manufactures, and sells medicines in the People's Republic of China. It offers small molecule and recombinant protein drugs for the treatment of liver cancer, non-small cell lung cancer, colorectal cancer, thyroid cancer, nasopharyngeal carcinomas, myelofibrosis, hemorrhage, and hepatobiliary diseases. The company was founded in 2009 and is based in Kunshan, the People's Republic of China. Address: No. 209, Chenfeng Road, Kunshan, China, 215300
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service

